Onderneming Benitec Biopharma Limited Deutsche Boerse AG
Aandelen
Biotechnologie & Medisch Onderzoek
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jerel Banks
CEO | Chief Executive Officer | 49 | 01-10-16 |
Peter Roelvink
CTO | Chief Tech/Sci/R&D Officer | - | 01-03-15 |
Megan Boston
CMP | Compliance Officer | 52 | 01-08-16 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
J. Buchi
BRD | Director/Board Member | 69 | 01-04-13 |
Edward Smith
BRD | Director/Board Member | 53 | 14-04-20 |
Peter Francis
BRD | Director/Board Member | 68 | 01-02-06 |
Jerel Banks
CEO | Chief Executive Officer | 49 | 01-10-16 |
Megan Boston
CMP | Compliance Officer | 52 | 01-08-16 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 9 367 485 | 8 497 929 ( 90,72 %) | 0 | 90,72 % |
Bedrijfsgegevens
![Adres Benitec Biopharma Limited](https://cdn.zonebourse.com/static/address/453260.png)
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+25,83% | 47,96 mld. | |
+45,66% | 41,47 mld. | |
+0,69% | 42,45 mld. | |
+30,52% | 31,6 mld. | |
+22,30% | 28,63 mld. | |
-6,35% | 28,03 mld. | |
+49,25% | 14,56 mld. | |
+49,18% | 14,14 mld. | |
+3,45% | 12,58 mld. |